Contributors
Sanjay B. Maggirwar: Role: Editor
Journal
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
25
February
2016
Publication date Collection: 2016
Volume: 11
Issue: 2
Electronic Location Identifier: e0149974
Affiliations
[1
]Department of Medicine, McGill University, Montreal, Quebec, Canada
[2
]Department of Pathology, McGill University, Montreal, Quebec, Canada
[3
]Department of Pharmacology & Therapeutics, McGill University, Montreal, Québec, Canada
[4
]Respiratory Epidemiology and Clinical Research Unit, Research Institute of the McGill
University Health Center, Montreal, Québec, Canada
[5
]Meakins Christie Laboratories, McGill University, Montreal, Québec, Canada
University of Rochester Medical Center, UNITED STATES
Author notes
Competing Interests: JB reports grants from the Canadian Institute of Health Research, CanCOLD Operating
grant Collaborative Program Rx&D (Almirall, Astra Zeneca, Boehringer Ingelheim, GSK,
Merck, Novartis, Takeda) and the Canadian Respiratory Research Network (CRRN), grants
from Fonds de Recherche du Quebec-Sante (FRQ-S) RHN COPD, research and educational
grants from Almirall, Astra Zeneca, Boehringer Ingelheim, GSK, Merck, Novartis for
investigator initiated projects. All remaining author(s) declare that they have no
competing interests. This does not alter the authors’ adherence to PLOS ONE policies
on sharing data and materials.
Conceived and designed the experiments: LL SSD JB CB. Performed the experiments: LL
MZ PC KG. Analyzed the data: LL MZ PC KG. Contributed reagents/materials/analysis
tools: SSD CB. Wrote the paper: LL SSD JB CB.
Article
Publisher ID:
PONE-D-15-49706
DOI: 10.1371/journal.pone.0149974
PMC ID: 4767820
PubMed ID: 26914709
SO-VID: 38eeb5c2-3089-4796-a429-fa634b5f9545
Copyright © © 2016 Labonté et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
History
Date
received
: 13
November
2015
Date
accepted
: 8
February
2016
Page count
Figures: 3,
Tables: 2,
Pages: 13
Funding
This study was funded as an investigator-initiated grant by GlaxoSmithKline Canada
Ltd. LL was funded by a Canadian Institute of Health Research Doctoral Award. Infrastructure
for this project was supported by the Canada Foundation for Innovation (CFI) -Leaders
Opportunities Fund (CJB). CJB was supported by a salary award from the Fonds de Recherche
du Quebec- Sante (FRQ-S).The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Categories
Subject:
Research Article
Subject:
Medicine and Health Sciences
Subject:
Pulmonology
Subject:
Chronic Obstructive Pulmonary Disease
Subject:
Biology and Life Sciences
Subject:
Immunology
Subject:
Immune Response
Subject:
Inflammation
Subject:
Medicine and Health Sciences
Subject:
Immunology
Subject:
Immune Response
Subject:
Inflammation
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Signs and Symptoms
Subject:
Inflammation
Subject:
Physical Sciences
Subject:
Materials Science
Subject:
Material Properties
Subject:
Mechanical Properties
Subject:
Stiffness
Subject:
Biology and Life Sciences
Subject:
Biochemistry
Subject:
Biomarkers
Subject:
Medicine and Health Sciences
Subject:
Health Care
Subject:
Health Care Facilities
Subject:
Hospitals
Subject:
Medicine and Health Sciences
Subject:
Inflammatory Diseases
Subject:
Physical Sciences
Subject:
Materials Science
Subject:
Materials by Attribute
Subject:
Surfactants
Subject:
Medicine and Health Sciences
Subject:
Vascular Medicine
Subject:
Blood Pressure
Custom metadata